Increase cancer treatment success rates with LBL’s revolutionary liquid biopsy for cancer screening and diagnosis.
"Liquid biopsies," one of the hottest trends in oncology, couldyield a less painful and risky...Pollack, Andrew
"We submitted samples from 40 men with metastatic prostate cancer to two liquid biopsy providers, which report having high sensitivity, specificity, and accuracy to detect mutations in tumour cfDNA in peripheral blood," explains Gonzalo Torga from the James Buchanan Brady Urological Institute in ...
"This is like a liquid biopsy" that avoids painful tissue sampling and may give a better way to monitor patients than periodic imaging scans, said Dr. Daniel Haber, chief of Massachusetts General Hospital's cancer center and one of the test's inventors. The test could transform care...
Karius, based in Redwood City, California, USA, sees this as three million opportunities to improve patient outcomes and change lives. The company has developed the Karius Test, a cell-free DNA (cfDNA)-based blood test much like the liquid biopsies that detect cancer DNA from a single blood...
It was the first PCR-based ctDNA test designed to detect epidermal growth factor receptor (EGFR) gene mutations from the blood of patients with non–small cell lung cancer (NSCLC). PCR-based detection of ctDNA in liquid biopsy is considered an attractive approach to molecular cancer screening ...
point is early detection via cell-free DNA (cfDNA) circulating in the bloodstream – the so-called “liquid biopsy.” However, using this method to detect cancer at its early stages has been challenging due to the genetic diversity of cancer and low tumor concentrations in DNA blood f...
Two experts in the management of prostate cancer provide key insight into the value of blood and urine liquid biopsy tests when deciding whether to perform a prostate tissue biopsy.
Molecular diagnostics companyPetDxhas published the results of a clinical validation study for its proprietary product, OncoK9, a multi-cancer early detection (MCED) test for dogs that uses next-generation sequencing (NGS) of blood-derived DNA. ...
metabolites have great promise as noninvasive biomarkers for cancer detection. Therefore, this review summarizes reported abnormal cancer-related metabolites in the last decade and highlights the application of metabolomics in liquid biopsy, including detection specimens, technologies, methods, and challenges...